G1 Therapeutics (GTHX) P/E US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/E | ? | -6.87 | -2.89 | -1.61 | -1.61 | -3.29 | -1.89 | ||
Changes by years, y/y, % | -15% | -58% | -44% | 0% | +105% | -15.2% |
G1 Therapeutics. P/E
G1 Therapeutics. P/E, changes, %
G1 Therapeutics (GTHX) P/E US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
P/E | ? | -1.55 | -0.99 | -2.99 | -7.37 | -2.67 | -1.89 | |
Changes by years, y/y, % | +30% | -71% | +81% | +610% | +72% | |||
Changes by quarters, q/q, % | +50% | -37% | +203% | +147% | -64% |